Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs by KATIE THOMAS

This entry was posted in Health Weight Watchers and tagged Health NYT on by

The lawsuit accused the pharmaceutical company of marketing Thalomid and Revlimid for unapproved use on a broader range of cancers.

Published: July 25, 2017 at 02:00AM

from NYT Health https://ift.tt/2uvw3P1